Suppr超能文献

α1-抗胰蛋白酶功能化胶体微载体对人中性粒细胞弹性蛋白酶的抑制作用。

Inhibition of human neutrophil elastase by α1-antitrypsin functionalized colloidal microcarriers.

机构信息

Institute for Medical Physics and Biophysics, Medical Faculty, University of Leipzig, Härtelstr 16-18, 04107 Leipzig, Germany.

出版信息

ACS Nano. 2012 Jul 24;6(7):6325-36. doi: 10.1021/nn301791w. Epub 2012 Jun 25.

Abstract

Layer-by-layer (LbL)-coated microcarriers offer a good opportunity as transport systems for active agents into specific cells and tissues. The assembling of oppositely charged polyelectrolytes enables a modular construction of the carriers and therefore an optimized integration and application of drug molecules. Here, we report the multilayer incorporation and transport of α(1)-antitrypsin (AT) by colloidal microcarriers. AT is an anti-inflammatory agent and shows inhibitory effects toward its pro-inflammatory antagonist, human neutrophil elastase (HNE). The highly proteolytic enzyme HNE is released by polymorphonuclear leukocytes (PMNs) during inflammatory processes and can cause host tissue destruction and pain. The high potential of this study is based on a simultaneous intra- and extracellular application of AT-functionalized LbL carriers. Carrier application in PMNs results in significant HNE inhibition within 21 h. Microcarriers phagocytosed by PMNs were time dependently decomposed inside phagolysosomes, which enables the step-by-step release of AT. Here, AT inactivates HNE before being released, which avoids a further HNE concentration increase in the extracellular space and, subsequently, reduces the risk of further tissue destruction. Additionally, AT surface-functionalized microcarriers allow the inhibition of already released HNE in the extracellular space. Finally, this study demonstrates the successful application of LbL carriers for a concurrent extra- and intracellular HNE inhibition aiming the rebalancing of protease and antiprotease concentrations and the subsequent termination of chronic inflammations.

摘要

层层(LbL)包裹的微载体为将活性物质主动递送至特定细胞和组织的运输系统提供了良好的机会。带相反电荷的聚电解质的组装使得载体具有模块化结构,从而可以优化药物分子的整合和应用。在这里,我们报告了胶体微载体中 α(1)-抗胰蛋白酶(AT)的多层包裹和运输。AT 是一种抗炎剂,对其促炎拮抗剂人中性粒细胞弹性蛋白酶(HNE)具有抑制作用。高度蛋白水解的酶 HNE 在炎症过程中由多形核白细胞(PMN)释放,并可能导致宿主组织破坏和疼痛。这项研究的高潜力基于 AT 功能化 LbL 载体的同时细胞内和细胞外应用。PMNs 中的载体应用可在 21 小时内显著抑制 HNE。被 PMNs 吞噬的微载体在吞噬溶酶体中随时间分解,从而使 AT 逐步释放。在这里,AT 在被释放之前失活 HNE,从而避免了细胞外空间中 HNE 浓度的进一步增加,并随后降低了进一步组织破坏的风险。此外,AT 表面功能化的微载体允许抑制细胞外空间中已经释放的 HNE。最后,这项研究成功地应用了 LbL 载体来同时抑制细胞外和细胞内的 HNE,旨在重新平衡蛋白酶和抗蛋白酶的浓度,并随后终止慢性炎症。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验